11/25
08:59 am
bsem
BioStem Technologies Expands Product Access in Medicaid
Medium
Report
BioStem Technologies Expands Product Access in Medicaid
11/5
04:05 pm
bsem
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
Medium
Report
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
11/5
07:00 am
bsem
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
Low
Report
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
10/31
07:00 am
bsem
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
Medium
Report
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
10/30
04:05 pm
bsem
BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
Medium
Report
BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
10/27
04:15 pm
bsem
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
Medium
Report
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
10/2
12:00 pm
bsem
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
Neutral
Report
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program